BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/23/2021 1:30:21 PM | Browse: 347 | Download: 621
 |
Received |
|
2021-02-24 07:59 |
|
Peer-Review Started |
|
2021-02-24 08:07 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-04-20 02:19 |
|
Revised |
|
2021-04-30 09:24 |
|
Second Decision |
|
2021-06-17 12:31 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-06-17 12:51 |
|
Articles in Press |
|
2021-06-17 12:51 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-06-24 21:40 |
|
Typeset the Manuscript |
|
2021-07-21 12:02 |
|
Publish the Manuscript Online |
|
2021-07-23 13:30 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Stem cell therapy: A paradigm shift in breast cancer treatment
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sabiha Khan, Moushumi Suryavanshi, Jasamrit Kaur, Debadatta Nayak, Anil Khurana, Raj Kumar Manchanda, Chanderdeep Tandon and Simran Tandon |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Central Council for Research in Homeopathy (CCRH), AYUSH (Govt. of India) |
17-03/2019-20/CCRH/Tech/Coll/Amity/7284 |
|
| Corresponding Author |
Simran Tandon, PhD, Professor, Amity Institute of Molecular Medicine and Stem Cell Research, Amity University, Sector 125, Noida 201313, Uttar Pradesh, India. standon1@amity.edu |
| Key Words |
Molecular genomics; Breast cancer stem cells; Tumor microenvironment; Molecular pathways; Targeted therapy; Inhibitors |
| Core Tip |
Breast cancer is a complex, heterogeneous disease with distinct cancer subtypes, identified through gene expression profiling. The aim of this review is to understand the pathway driven, mechanistic control of breast cancer stem cells (BCSCs) and explore the clinical and experimental studies investigating the role of BCSCs in disease progression. Key factors that are pivotal in BCSCs growth and their malignant behavior in breast cancer will be elucidated. |
| Publish Date |
2021-07-23 13:30 |
| Citation |
Khan S, Suryavanshi M, Kaur J, Nayak D, Khurana A, Manchanda RK, Tandon C, Tandon S. Stem cell therapy: A paradigm shift in breast cancer treatment. World J Stem Cells 2021; 13(7): 841-860 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i7/841.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i7.841 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
